bệnh huyết học

13 · 20 / page

Ask MedXY AI

Latest news

Tag

$Complement Activation May Define a Refractory Subset of Adult ITP$

Hematology-Oncologybệnh huyết họccomplement activation

Complement Activation May Define a Refractory Subset of Adult ITP

By MedXY|Jun 19, 2026

Complement deposition on platelets identifies a biologically distinct subset of adult ITP associated with higher platelet turnover and more first-line treatment refractoriness.

Hematology-Oncologybệnh huyết họcethnic disparities

bệnh huyết học

Latest news

Complement Activation May Define a Refractory Subset of Adult ITP

Ethnicity Influences Relapse-Free Survival in Immune-Mediated Thrombotic Thrombocytopenic Purpura

Optimizing CML Management: Clinical Synthesis of the ASC4OPT Study and the Allosteric Inhibition Paradigm

2/20/20 Model Outperforms AQUILA Criteria in Identifying High-Risk Smoldering Multiple Myeloma

Immunophenotypic Evolution and Clinical Outcomes in R/R AML Treated with Revumenib

Predictive Value of Sex Chromosome Loss in Sex-Mismatched Stem Cell Transplantation

Optimizing Iron Deficiency Management in Pregnancy: A Synthesis of Evidence for Intravenous Ferumoxytol vs. Oral Ferrous Sulfate

Improving Survival in Advanced Proliferative CMML: The Prognostic Impact of Stringent Cytoreduction and Novel Flow Cytometric Biomarkers

Standardized DOAC Interruption Protocols Result in Low Residual Levels, but Apixaban and Renal Impairment Merit Closer Monitoring

Engineering a Cure: How CAR T-Cell Therapy is Transforming the Fight Against Autoimmune Hemolytic Anemia

Addressing the Silent Crisis: Menstrual Pain and Abnormal Bleeding as Drivers of Acute Care in Sickle Cell Disease

Short-Course Ianalumab Combined with Eltrombopag: A Potential Shift Toward Sustained Remission in Immune Thrombocytopenia

B-Cell Depletion Meets TPO-RA: Ianalumab and Eltrombopag Redefine Treatment Success in Immune Thrombocytopenia